Figure 5
From: Levels of S100B are raised in female patients with schizophrenia
S100B concentration in female patients treated with clozapine and healthy control subjects. (A) Data shows significant statistical difference in BMI levels between male (31.37 +/− 0.69, n = 68) and female (35.31 +/− 1.16, n = 29) patients treated with clozapine. BMI levels in female patients also showed significant statistical significance compared to female controls (27.38 +/− 1.01, n = 17) and male controls (27.24 +/− 1.69, n = 10) (p = 0.0001, male patients and female controls vs. female patients, one-way ANOVA and Bonferroni post-hoc test). Data represented as mean +/− SEM. Number of subjects in parenthesise. Correlation between S100B concentration and BMI for (B) male and (C) female patients treated with clozapine. A significant correlation was observed for S100B concentration and BMI in female patients treated with clozapine (Pearson r = 0.4868; p value (two tailed) = 0.0117). Number of subjects in parenthesise.